Search Articles
Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.
Promega and EraGen sign technology licensing agreement
March 10, 2004
Madison, Wis. -- Promega Corporation and EraGen Biosciences, two Madison-based life science companies, signed a licensing agreement Wednesday allowing Promega to develop products using EraGen’s research assays. The partnership also grants Promega global distribution rights for research assays. “Promega should expect rapid market acceptance as validated by our recent SARS detection system. A market presence by Promega will further enhance EraGen’s product development for the clinical diagnostic market,” said Irene Hrusovsky, president and chief of operations of EraGen.
EraGen will provide its chemistry and software to analyze test results. Promega will develop and manufacture reagent systems in its Madison facility with the first branded product scheduled to be launched this year.
EraGen develops and commercializes molecular diagnostics. Promega provides technical support to the life sciences industry by combining chemistry and software.
Add Your Comment
Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and not immediately posted. Your email address will not be posted.
WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.
Advertisement
Most Popular Stories
Advertisement
Featured EventsMore…
- Apr 14 BioForward Professional Development Series - Managing Performance
- Apr 21 BioForward Professional Development Series - Project Management Essentials
- Apr 21 5th Annual Wisconsin Stem Cell Symposium -- The Road to Stem Cell Applications: Bioprocessing, Safety and Preclinical Evaluation
- Apr 22 - 23 9th Annual International Bioethics Forum - Taking the Measure of the Magic Mirror: Toward a Science of Consciousness
- Apr 22 UW-Madison IT Business Alignment Course
- May 19 - 20 Digital Healthcare Conference
- Oct 4 - 6 2010 World Stem Cell Summit
More Stories
- Twitter becoming essential tool for docs
- For Chinese people, loss of Google would mean 'nothing but darkness'
- March Madness means that half the year has passed.
- CIO drives IT business value with new perspective on processes
- Perspective matters when considering IT investment budgets
- The National Broadband Plan needs to be fixed -- already
- March Madness: IT Companies head to the big dance
- Theory meets practice in entrepreneurial bootcamp
- Core BTS will transition to new CEO based in Madison
- Measure would force White House, private sector to collaborate in cyber-crisis
WTN Media Presents
